0001384101-24-000047.txt : 20240402
0001384101-24-000047.hdr.sgml : 20240402
20240402161753
ACCESSION NUMBER: 0001384101-24-000047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EASTHAM KARIN
CENTRAL INDEX KEY: 0001231845
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 24814453
MAIL ADDRESS:
STREET 1: C/O BURNHAM INSTITUTE FOR MEDICAL RESEAR
STREET 2: 10901 N. TORREY PINES ROAD
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
wk-form4_1712089048.xml
FORM 4
X0508
4
2024-04-01
0
0001384101
VERACYTE, INC.
VCYT
0001231845
EASTHAM KARIN
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Common Stock
2024-04-01
4
M
0
10000
13.19
A
43125
D
Common Stock
2024-04-01
4
S
0
10000
21.6528
D
33125
D
Stock Option (right to buy)
13.19
2024-04-01
4
M
0
10000
13.19
D
2024-05-20
Common Stock
10000
0
D
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 18, 2022.
Represents weighted average sales price. Sale prices for the transactions range from $21.45 to $22.09. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
The option is fully vested.
/s/ Jonathan Wygant as attorney-in-fact
2024-04-02